BIOMAT Database Logo BIOMAT Database Logo

Use of somatostatin analogues in terminal cancer patients. 1993

R L Fainsinger, and A Pisani, and E Bruera
Palliative Care Program, Edmonton General Hospital, Alberta, Canada.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D010166 Palliative Care Care alleviating symptoms without curing the underlying disease. (Stedman, 25th ed) Palliative Treatment,Palliative Supportive Care,Palliative Surgery,Palliative Therapy,Surgery, Palliative,Therapy, Palliative,Care, Palliative,Palliative Treatments,Supportive Care, Palliative,Treatment, Palliative,Treatments, Palliative
D005260 Female Females
D005767 Gastrointestinal Diseases Diseases in any segment of the GASTROINTESTINAL TRACT from ESOPHAGUS to RECTUM. Cholera Infantum,Gastrointestinal Disorders,Functional Gastrointestinal Disorders,Gastrointestinal Disorders, Functional,Disease, Gastrointestinal,Diseases, Gastrointestinal,Functional Gastrointestinal Disorder,Gastrointestinal Disease,Gastrointestinal Disorder,Gastrointestinal Disorder, Functional
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000369 Aged, 80 and over Persons 80 years of age and older. Oldest Old

Related Publications

R L Fainsinger, and A Pisani, and E Bruera
Use of somatostatin analogues in obesity.
January 2008, Drugs,
R L Fainsinger, and A Pisani, and E Bruera
The clinical use of somatostatin analogues in the treatment of cancer.
March 1990, Bailliere's clinical endocrinology and metabolism,
R L Fainsinger, and A Pisani, and E Bruera
[Therapeutic use of somatostatin analogues in endocrinology].
November 1992, Recenti progressi in medicina,
R L Fainsinger, and A Pisani, and E Bruera
Somatostatin analogues for somatostatin-receptor-mediated radiotherapy of cancer.
January 1996, Digestion,
R L Fainsinger, and A Pisani, and E Bruera
Somatostatin analogues: are they analogues of somatostatin?
April 2002, Journal of endocrinological investigation,
R L Fainsinger, and A Pisani, and E Bruera
Clinical use of somatostatin analogues in paediatric oncology.
January 1996, Digestion,
R L Fainsinger, and A Pisani, and E Bruera
When and How to Use Somatostatin Analogues.
September 2018, Endocrinology and metabolism clinics of North America,
R L Fainsinger, and A Pisani, and E Bruera
The use of long-acting somatostatin analogues in acromegaly.
April 2000, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society,
R L Fainsinger, and A Pisani, and E Bruera
Somatostatin and somatostatin analogues in oncology.
June 1989, Cancer treatment reviews,
R L Fainsinger, and A Pisani, and E Bruera
Probable adverse effects of long term use of somatostatin analogues in patients with RA.
December 2002, Annals of the rheumatic diseases,
Copied contents to your clipboard!